The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

by Papi A, Jones PW, Dalvi PS, McAulay K, McIver T, Dissanayake S
Published 2015-11-01

Fluticasone propionate/formoterol for COPD management: a randomized controlled trial

by Papi A, Dokic D, Tzimas W, Mészáros I, Olech-Cudzik A, Koroknai Z, McAulay K, Mersmann S, Dalvi PS, Overend T
Published 2017-07-01